Afya (NASDAQ:AFYA) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Afya (NASDAQ:AFYAGet Free Report) released its earnings results on Friday. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.40 by $0.03, FiscalAI reports. Afya had a net margin of 20.20% and a return on equity of 17.94%. The firm had revenue of $187.80 million for the quarter, compared to the consensus estimate of $189.62 million.

Afya Trading Up 3.2%

AFYA traded up $0.43 during trading on Friday, hitting $13.84. 168,637 shares of the company’s stock were exchanged, compared to its average volume of 105,660. The firm has a market cap of $1.30 billion, a P/E ratio of 9.05, a price-to-earnings-growth ratio of 1.45 and a beta of 0.34. The stock has a 50 day moving average price of $14.27 and a 200 day moving average price of $14.42. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya has a 1 year low of $13.00 and a 1 year high of $16.50.

Wall Street Analyst Weigh In

AFYA has been the subject of a number of research reports. Zacks Research cut shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. cut their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, June 22nd. Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. Bank of America reissued a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Finally, Weiss Ratings downgraded Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Six research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.00.

Get Our Latest Stock Analysis on Afya

Insider Activity

In other news, VP Lelio De Souza Junior sold 36,204 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the transaction, the vice president directly owned 34,530 shares in the company, valued at approximately $511,044. This trade represents a 22.46% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 87,745 shares of company stock worth $1,314,175. 0.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Afya

Several hedge funds have recently modified their holdings of AFYA. Mangrove Partners IM LLC purchased a new position in Afya during the fourth quarter worth about $197,000. Susquehanna International Group LLP purchased a new stake in Afya during the 3rd quarter worth $419,000. Sei Investments Co. bought a new stake in Afya in the third quarter valued at $244,000. Lazard Asset Management LLC lifted its position in shares of Afya by 166.6% during the 2nd quarter. Lazard Asset Management LLC now owns 18,463 shares of the company’s stock valued at $329,000 after acquiring an additional 11,537 shares during the last quarter. Finally, Engineers Gate Manager LP acquired a new stake in Afya in the second quarter valued at approximately $363,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Featured Stories

Earnings History for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.